See All of This Company's Exhibits Find More Exhibits Like This
![]() |
PRESS RELEASE | NASDAQ: IPX | ASX: IPX
|
December 8, 2022
|
▪ |
IperionX has extended the purchase and license option agreements over the patented ‘titanium technologies’ from Blacksand Technology LLC
|
▪ |
The titanium technologies represent the only commercially available 100% fully circular, low-carbon titanium production process and were recently instrumental in producing the first circular ‘production series’ 3D printed titanium watch
blanks for the Officine Panerai, a division of Compagnie Financière Richemont SA
|
▪ |
The revised agreement retains the option to acquire the full range of Blacksand technologies including HAMR, GSD, low carbon synthetic rutile, titanium alloying, zirconium metal and rare earth recycling as well as retaining the option to
secure the exclusive rights to the global licenses over all intellectual property held by Blacksand
|
▪ |
The revised agreement extends the option expiry date by two years to December 31, 2024
|
▪ |
This successful renegotiation extends the timing of both cash and equity payments to Blacksand, materially reduces IperionX’s near term capital requirements, providing a pathway to potentially accelerate the development of the Titanium
Demonstration Facility in South Boston, Virginia
|
![]() |
Corporate Office
|
Tennessee Office
|
Salt Lake City Office
|
129 W Trade St, Suite 1405 Charlotte, NC 28202
|
279 West Main St, Camden, TN 38320
|
1782 W 2300 S, West Valley City, UT 84119
|
Forward Looking Statements
Information included in this release constitutes forward-looking statements. Often, but not always,
forward looking statements can generally be identified by the use of forward-looking words such as “may”, “will”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “continue”, and “guidance”, or other similar words and may include,
without limitation, statements regarding plans, strategies and objectives of management, anticipated production or construction commencement dates and expected costs or production outputs.
Forward looking statements inherently involve known and unknown risks, uncertainties and other factors
that may cause the Company’s actual results, performance, and achievements to differ materially from any future results, performance, or achievements. Relevant factors may include, but are not limited to, changes in commodity prices,
foreign exchange fluctuations and general economic conditions, increased costs and demand for production inputs, the speculative nature of exploration and project development, including the risks of obtaining necessary licenses and
permits and diminishing quantities or grades of reserves, the Company’s ability to comply with the relevant contractual terms to access the technologies, commercially scale its closed-loop titanium production processes, or protect its
intellectual property rights, political and social risks, changes to the regulatory framework within which the Company operates or may in the future operate, environmental conditions including extreme weather conditions, recruitment and
retention of personnel, industrial relations issues and litigation.
Forward looking statements are based on the Company and its management’s good faith assumptions relating
to the financial, market, regulatory and other relevant environments that will exist and affect the Company’s business and operations in the future. The Company does not give any assurance that the assumptions on which forward looking
statements are based will prove to be correct, or that the Company’s business or operations will not be affected in any material manner by these or other factors not foreseen or foreseeable by the Company or management or beyond the
Company’s control.
Although the Company attempts and has attempted to identify factors that would cause
actual actions, events or results to differ materially from those disclosed in forward looking statements, there may be other factors that could cause actual results, performance, achievements, or events not to be as anticipated,
estimated or intended, and many events are beyond the reasonable control of the Company. Accordingly, readers are cautioned not to place undue reliance on forward looking statements. Forward looking statements in these materials speak
only at the date of issue. Subject to any continuing obligations under applicable law or any relevant stock exchange listing rules, in providing this information the Company does not undertake any obligation to publicly update or revise
any of the forward-looking statements or to advise of any change in events, conditions or circumstances on which any such statement is based.
|
• |
Key parties: IperionX Limited and Blacksand Technologies, LLC
|
• |
Option period: From signing until December 31, 2024
|
• |
Option payments: $6m in total, with payments of $1.5m payable on each of January 2023, July 2023, January 2024 and July 2024, all of which may be credited towards either the
purchase price or license price at IperionX’s election
|
• |
Other: During the two-year option period, Blacksand grants IperionX an exclusive, limited, royalty-free, license to develop the Blacksand IP for commercial purposes
|
• |
Scope: All Blacksand assets including commercialization rights to its intellectual property
|
• |
Purchase price: $12m
|
• |
Equity consideration: At IperionX’s election, and subject to shareholder approval, 30% ($3.6m) of the purchase price can be paid in IperionX shares
|
• |
Royalties: 0.5% of net sales in excess of $300m for the life of the patented technology
|
Blacksand purchase option - Key terms
|
||
|
Original
|
Revised
|
Option purchase price
|
$12m
|
$12m
|
Option / purchase
payment profile
|
$12m payment on December 31, 2022
|
4x $1.5m payments over eighteen months
+ 1x $6m payment on December 31, 2024
|
% payable in scrip
|
30%, payable at option exercise
|
30%, payable at option exercise
|
Option expiry date
|
December 31, 2022
|
December 31, 2024
|
• |
Scope: All Blacksand intellectual property
|
• |
License fee: $8m
|
• |
Royalties: 3% of net sales for HAMR products and 5% of net sales for GSD products, with a minimum annual royalty of $400,000 from the third anniversary of exercising the option
through the life of the patented technologies
|
i |
Refer to ASX announcement dated February 15, 2021, link.
|
ii |
Refer to ASX announcement dated June 10, 2021, link.
|
iii |
Refer to ASX announcement dated August 9, 2022, link.
|
iv |
Refer to ASX announcement dated August 26, 2022, link.
|